Does ISATUXIMAB Cause Basal cell carcinoma? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Basal cell carcinoma have been filed in association with ISATUXIMAB (Sarclisa). This represents 0.9% of all adverse event reports for ISATUXIMAB.
34
Reports of Basal cell carcinoma with ISATUXIMAB
0.9%
of all ISATUXIMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From ISATUXIMAB?
Of the 34 reports, 3 (8.8%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ISATUXIMAB. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does ISATUXIMAB Cause?
Neutropenia (396)
Pneumonia (304)
Covid-19 (248)
Plasma cell myeloma (241)
Thrombocytopenia (227)
Infusion related reaction (213)
Pyrexia (202)
Anaemia (197)
Diarrhoea (162)
Off label use (126)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which ISATUXIMAB Alternatives Have Lower Basal cell carcinoma Risk?
ISATUXIMAB vs ISATUXIMAB-IRFC
ISATUXIMAB vs ISAVUCONAZOLE
ISATUXIMAB vs ISAVUCONAZONIUM
ISATUXIMAB vs ISCALIMAB
ISATUXIMAB vs ISENTRESS